STAHLBERG JAN bought DMAC
August 26, 2025 · Form 4 insider transaction
STAHLBERG JAN bought 59,648 shares of DiaMedica Therapeutics Inc. at $6.00 per share, a transaction worth $357.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Acquired (buy-side)
Shares
59,648
Price
$6.00
Total value
$357.9K
InsiderSTAHLBERG JAN
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateAugust 26, 2025
Filing dateSeptember 4, 2025
Shares owned after7,713,693
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.